Business Wire

MI-EATON

25.8.2021 12:32:04 CEST | Business Wire | Press release

Share
Eaton’s Vehicle Group Unveils Complete Range of Differentials for Electrified Vehicles

Power management company Eaton today announced its Vehicle Group has launched an extensive lineup of specialized differentials for electrified vehicles with comparable performance to traditional internal combustion engine (ICE) vehicles. The passenger vehicle market is increasingly transitioning to electrified vehicles (EVs), and Eaton has the expertise and experience to provide the solution EV manufacturers need.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210825005114/en/

Eaton’s Traction Control family of differentials can provide improved traction in adverse conditions, such as snow and mud, and improved stability while trailering. As a global supplier, Eaton has extensive knowledge of vehicle dynamics and safety standards, as well as decades of experience working with global automotive manufacturers to integrate differentials into new vehicle platforms. Eaton has been supplying differentials to the EV market since 2015.

“Eaton conducts a total system analysis, using state-of-the-art tools and in-house know-how, to design a differential for electrified vehicles optimized for efficiency, reliability and manufacturing,” said Brent Pawlak, business unit director, Eaton’s Vehicle Group. “We also can partner with an OEM to design and develop a differential to specifications and requirements, including torque levels, duty cycles, fatigue and size requirements, as EVs often require compact components and unique torque requirements that can be integrated into electrified drivetrains.”

Eaton offers a full range of differentials for electrified vehicles, including automatic limited-slip, automatic locking and electronic selectable locking differentials. Each differential is highly engineered, tested and validated for a variety of traction control applications. Performance is verified at Eaton’s Proving Ground testing complex in Marshall, Michigan, which is home to more than 600 acres of testing facilities and tracks.

Eaton’s Traction Control solutions include:

  • Truetrac® – Helical-gear limited-slip differential maximizes wheel traction and enhances driving and handling characteristics. Easily integrated into compact packaging spaces, with high power density capacity.
  • ELocker® – Allows for maximum driveline flexibility. Users can switch from a fully open to a fully locked axle at the touch of a button, or it can be integrated into the vehicle (auto-locking). High torque capacity and range, with compact designs for EV applications.
  • IntelliTrac™ – Smart electronically controlled, limited-slip differential is fully integrated to the vehicle to provide instant response and optimized vehicle performance at any speed or traction condition.
  • MLocker® – Automatic, mechanical locking differential which provides drivers best-in-class traction without the need for buttons, shift knobs or other driver intervention. Improves towing and off-road performance with low integration cost.
  • Posi® – Limited slip differential which automatically prevents wheel slip before it can get started. Easily integrates into most axle designs and can be tuned for application requirements.
  • Open – Compact open differential which allows cost-effective solution for managing torque between left and right wheels.

Eaton’s mission is to improve the quality of life and the environment through the use of power management technologies and services. We provide sustainable solutions that help our customers effectively manage electrical, hydraulic, and mechanical power – more safely, more efficiently, and more reliably. Eaton’s 2020 revenues were $17.9 billion, and we sell products to customers in more than 175 countries. We have approximately 85,000 employees. For more information, visit www.eaton.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye